These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 15983428

  • 1. Inefficacy of piracetam in the prevention of painful crises in children and adolescents with sickle cell disease.
    Alvim RC, Viana MB, Pires MA, Franklin HM, Paula MJ, Brito AC, Oliveira TF, Rezende PV.
    Acta Haematol; 2005; 113(4):228-33. PubMed ID: 15983428
    [Abstract] [Full Text] [Related]

  • 2. Painful crises in children with sickle cell disease are not prevented by piracetam.
    Viana MB, Alvim RC.
    Acta Haematol; 2009; 121(1):9-10. PubMed ID: 19246889
    [No Abstract] [Full Text] [Related]

  • 3. Piracetam for reducing the incidence of painful sickle cell disease crises.
    Al Hajeri AA, Fedorowicz Z, Omran A, Tadmouri GO.
    Cochrane Database Syst Rev; 2007 Apr 18; (2):CD006111. PubMed ID: 17443614
    [Abstract] [Full Text] [Related]

  • 4. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR.
    N Engl J Med; 1995 May 18; 332(20):1317-22. PubMed ID: 7715639
    [Abstract] [Full Text] [Related]

  • 5. Piracetam for reducing the incidence of painful sickle cell disease crises.
    Al Hajeri A, Fedorowicz Z.
    Cochrane Database Syst Rev; 2016 Feb 12; 2(2):CD006111. PubMed ID: 26869149
    [Abstract] [Full Text] [Related]

  • 6. High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease.
    Griffin TC, McIntire D, Buchanan GR.
    N Engl J Med; 1994 Mar 17; 330(11):733-7. PubMed ID: 8107739
    [Abstract] [Full Text] [Related]

  • 7. Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043).
    Ataga KI, Reid M, Ballas SK, Yasin Z, Bigelow C, James LS, Smith WR, Galacteros F, Kutlar A, Hull JH, Stocker JW, ICA-17043-10 Study Investigators.
    Br J Haematol; 2011 Apr 17; 153(1):92-104. PubMed ID: 21323872
    [Abstract] [Full Text] [Related]

  • 8. Piracetam is useful in the treatment of children with sickle cell disease.
    el-Hazmi MA, Warsy AS, al-Fawaz I, Opawoye AO, Taleb HA, Howsawi Z, Mohamed AA, Aly AW, Refai S, Sugathan PS, Rab AS, Ahmed HB, Abulaban M, Abdulkader AM, Farid M.
    Acta Haematol; 1996 Apr 17; 96(4):221-6. PubMed ID: 8922488
    [Abstract] [Full Text] [Related]

  • 9. Clinical response of patients with sickle cell anemia to cromolyn sodium nasal spray.
    Karimi M, Zekavat OR, Sharifzadeh S, Mousavizadeh K.
    Am J Hematol; 2006 Nov 17; 81(11):809-16. PubMed ID: 16941613
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Trial prevention of vaso-occlusive crises in homozygote sickle cell anemia using piracetam].
    Sonnet J, Gini EK, Cornu G.
    Ann Soc Belg Med Trop; 1985 Nov 17; 65(1):77-84. PubMed ID: 4004377
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Epidural analgesia in the management of severe vaso-occlusive sickle cell crisis.
    Yaster M, Tobin JR, Billett C, Casella JF, Dover G.
    Pediatrics; 1994 Feb 17; 93(2):310-5. PubMed ID: 8121746
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Placebo controlled double-blind study of pentoxifylline in sickle cell disease patients.
    Manrique RV.
    J Med; 1987 Feb 17; 18(5-6):277-91. PubMed ID: 3333162
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy of nalbuphine as a parenteral analgesic for the treatment of painful episodes in children with sickle cell disease.
    Woods GM, Parson PM, Strickland DK.
    J Assoc Acad Minor Phys; 1990 Feb 17; 1(3):90-2. PubMed ID: 2136623
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Double-blind randomised clinical trial of pentoxiphyllin in vaso-occlusive sickle cell crisis.
    Teuscher T, Von Der Ahe CW, Baillod P, Holzer B.
    Trop Geogr Med; 1989 Oct 17; 41(4):320-5. PubMed ID: 2635446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.